4//SEC Filing
COHEN ABRAHAM 4
Accession 0001201800-10-000053
CIK 0000839087other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 9:54 AM ET
Size
19.0 KB
Accession
0001201800-10-000053
Insider Transaction Report
Form 4
VASOMEDICAL INCVASO.OB
COHEN ABRAHAM
Director
Transactions
- Award
1999 Stock Option Plan, as amended Right to Buy
2004-02-20$1.31/sh+25,000$32,750→ 25,000 totalExercise: $1.31Exp: 2013-10-29→ Common Stock (25,000 underlying) - Award
1999 Stock Option Plan, as amended Right to Buy
2001-10-10$3.13/sh+15,000$46,950→ 15,000 totalExercise: $3.13Exp: 2011-10-09→ Common Stock (15,000 underlying) - Award
1999 Stock Option Plan
2006-11-02$0.09/sh+150,000$13,500→ 150,000 totalExercise: $0.09Exp: 2016-11-01→ Common Stock (150,000 underlying) - Award
1999 Stock Option Plan, as amended Right to Buy
2002-12-18$1.00/sh+15,000$15,000→ 15,000 totalExercise: $1.00Exp: 2012-12-17→ Common Stock (15,000 underlying) - Award
1999 Stock Option Plan, as amended Right to Buy
2000-10-11$3.88/sh+15,000$58,125→ 15,000 totalExercise: $3.88Exp: 2010-10-10→ Common Stock (15,000 underlying) - Award
Common Stock
2010-03-16+60,625→ 60,625 total(indirect: By Kramex Corporation) - Award
1999 Stock Option Plan
2004-10-28$0.95/sh+25,000$23,750→ 25,000 totalExercise: $0.95Exp: 2014-10-27→ Common Stock (25,000 underlying)
Holdings
- 1,308,254
Common Stock
Footnotes (5)
- [F1]Directors' annual fee.
- [F2]Options vest in three equal annual iinstallments.
- [F3]One-third vesting immediately, one-third in one year and one-third in two years.
- [F4]Director fees.
- [F5]The reporting person is the sole shareholder and sole director of Kramex Corporation. Accordingly, he has dispositive powers over these shares and, as a result, may be deemed to be the beneficial owner thereof.
Documents
Issuer
VASOMEDICAL INC
CIK 0000839087
Entity typeother
Related Parties
1- filerCIK 0001212109
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 9:54 AM ET
- Size
- 19.0 KB